PDA

View Full Version : USA: F.D.A.'s Report Illuminates Wide Divide on Marijuana


c-ray
04-25-2006, 04:53 AM
New York Times
April 24. 2006

Food and Drug Administration statement on Thursday denying any medical benefits of marijuana reinforced the divide between federal officials and the states that have approved the drug's use to ease some medical conditions.
"It's consistent with the long-held federal view on this medicine, and that is that marijuana is the equivalent of heroin and cocaine," said Nathan Barankin, a spokesman for California's attorney general, Bill Lockyer. "California voters disagree."

State officials said the announcement would not affect their laws. But they and federal officials said it clarified the federal government's intention to continue enforcing its laws against marijuana, even in states that allow it for medical purposes.

"It's a very good statement so that people can clearly see what the policy of the United States government is," said Rogene Waite, a spokeswoman for the Drug Enforcement Administration.

While it has always been the drug enforcement agency's policy to enforce laws against marijuana, Ms. Waite said, "now it's clearly out there, so that people don't have to look everywhere to figure this out."

Several officials in the 11 states that allow medical marijuana disputed the F.D.A.'s contention that there was no research supporting the drug's medical use. They noted, in particular, a 1999 review by the National Institute of Medicine, part of the National Academy of Sciences, the nation's most prestigious scientific advisory panel, which found marijuana to be "moderately well-suited" to some conditions, including wasting disease from AIDS and the nausea that often results from chemotherapy.

State officials said that most of their laws had been passed by citizen initiatives.

"The decision was made by the voters. It's not based on any conditions," said James M. Cameron, assistant attorney general in Maine, where the law allowing marijuana use under some conditions took effect in December 1999. "Really, there's nothing that's going to happen — any third parties judging whether these substances are effective — that is going to change Maine law."

But Mr. Cameron and other officials said they had warned people who used marijuana that they were protected under state law only, and could be prosecuted under federal laws.

"The Vermont attorney general's office had always been concerned about the message that the med marijuana program gave that it was legalizing it, when it remains illegal under federal law," said John Treadwell, an assistant attorney general in that office.

A United States Supreme Court decision last year affirmed the federal government's right to enforce those laws in those states.
State officials said they did not believe that the ruling would increase the number of federal prosecutions.

"There's sort of a détente," Mr. Barankin said, in California. "Both sides respect that we have laws that differ. Federal law enforcement agencies for the most part have shown some respect for California law by only going after those individuals who seem to be clearly not in the medical marijuana business for the medical part of it — which are the same people the state law is going after."

The Food and Drug Administration issued its announcement in response to calls from opponents of medical marijuana in Congress, and it was welcomed by the White House Office of National Drug Control Policy, which has long made marijuana its top priority.

Advocates of medical marijuana said the real impact would be in trying to pass new legislation in states like Connecticut, New Jersey and New Mexico.
"We're going to have members of state legislatures say, 'But even the F.D.A. has said there's no medical value,' " said Ethan Nadelmann, executive director of the Drug Policy Alliance, which works to loosen drug laws. "That's where it's going to hurt."

The Supreme Court decision killed efforts to allow medical marijuana in Connecticut, Mr. Nadelmann said, adding, "It had no legal impact, but it created a perception."

Others said the decision would continue to frustrate efforts to research the potential medical benefits of marijuana.

In Vermont, for example, a statute enacted several years ago called for a research program on the therapeutic effects of marijuana. When a legislative group asked more recently why that had not been conducted, the Vermont Health Department said it could not be done under federal law, Mr. Treadwell said.

clips
04-27-2006, 04:11 AM
some congressmens and asa's reply to the fda report . hehehe enjoy and please particpate .
thank you and ill chat ya later clips
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~

Urge Your Representative to Co-sign Congressional Letter to the FDA by Noon Thursday!

In response to the Food and Drug Administration’s (FDA) bogus April 20 press release condemning medical cannabis, Representatives Hinchey (D-NY) and Paul (R-TX) in collaboration with ASA have drafted a strongly worded letter to FDA asking the agency to either produce evidence of new research or explain motivation behind their statement. Call your Member of Congress NOW! Urge your Representative to co-sign the Hinchey letter to the FDA.

Actions to Take:

1. Call your Member of Congress at 202-224-3121. Ask your Representative to co-sign Congressman Hinchey’s letter to FDA no later than Thursday, April 27, 2006. Find out who your Representative by visiting http://www.house.gov/ and enter your zip code.


Call Script:

Hello, my name is (your name), and I am calling from (city, state). In response to the Food and Drug Administration’s (FDA) bogus April 20 press release condemning medical cannabis, Representatives Hinchey (D-NY) and Paul (R-TX) have drafted a letter to FDA asking the agency to either produce evidence of new research or explain motivation behind their statement. I am calling to urge Representative (your Representative’s Last Name) to co-sign this letter. For copies of their letter and to arrange your sign-on, please contact Terra in Congressman Hinchey’s office or call 202-225-6635.


2. Forward this alert to your family, friends, and neighbors!

For further information, please read ASA's analysis of the major problems with the FDA advisory, and read Congressman Hinchey's sign-on letter below or online.


--------------------------------------------------------------------------------


CONGRESSIONAL SIGN-ON LETTER TO THE FDA



April 27, 2005


Andrew C. von Eschenbach, M.D.
Acting Commissioner
Food and Drug Administration
5600 Fishers Lane
Rockville, Maryland 20857



Dear Dr. von Eschenbach:

We are troubled by the FDA's April 20th press release in which the agency states that "[N]o sound scientific studies supported medical use of marijuana for treatment in the United States, and no animal or human data supported the safety or efficacy of marijuana for general medical use." The timing and the lack of substantial information included in this release lead us to conclude that this was a politically motivated statement rather than one based on scientific evidence and fact.

Despite the fact that you are responding to a scientific question, your press release failed to provide any scientific expertise. We call on you to show us the purported scientific evidence for the basis of this response. There is no evidence that you have new scientific proof or that you oversaw clinical trials. In conjunction with the lack of scientific evidence, it is troubling that your release seemed to defer to the DEA's medical opinions on the drug despite the fact that determining the medical importance of a drug is not in the DEA's jurisdiction.

After deferring to the DEA, your release reads that, "FDA is the sole federal agency that approves drug products as safe and effective for intended indications." Why then has the FDA failed to respond to the 1999 Institute of Medicine (IOM) report which concluded that marijuana's active components are potentially effective in treating pain, nausea, the anorexia of AIDS wasting, and other symptoms, and should be tested rigorously in clinical trials? It perplexes us that even though the FDA is responsible for protecting public health, the agency has failed to respond adequately to the IOM's findings seven years after the study's publication date. Additionally, this release failed to make note of the FDA's Investigational New Drug (IND) Compassionate Access Program, which allowed patients with certain medical conditions to apply with the FDA to receive federal marijuana. Currently, seven people still enlisted in this program continue to receive marijuana through the federal government. The existence of this program is an example of how the FDA could allow for the legal use of a drug, such as medical marijuana, without going through the "well-controlled" series of steps that other drugs have to go through if there is a compassionate need.

In light of our distress over this release, please inform us if there is new scientific information that disputes the IOM study, including the results of the evaluation, any scientific paperwork generated in the study, the length of time the evaluation occurred, and whether the DEA or any other federal agencies aside from the ones mentioned in the letter had a role in the evaluation. If, as the press release leads us to believe, there is in fact no evaluation, please let us know what motivated the FDA to write a release that lacks scientific review. It disheartens us to see the FDA veer off course in this area of public health especially at the expense of many terminally ill Americans. We understand that FDA's mission is to protect public health, which is why we respectfully request that you respond to these questions on this very important issue.


Sincerely,


________________ _______________
/s /s
Maurice D. Hinchey Ron Paul
Member of Congress Member of Congress


________________ ________________
/s /s
Barney Frank Sam Farr
Member of Congress Member of Congress

--
Rebecca Saltzman
Field Coordinator
Americans for Safe Access
p (510) 251-1856 x 308
f (510) 251-2036
www.safeaccessnow.org





"If people let government decide which foods they eat and medicines they take, their bodies will soon be in as sorry a state as are the souls of those who live under tyranny."
- Thomas Jefferson -

"Abusus non tollit usum. [Abuse is no argument against proper use.]"
- Latin proverb -

"Much virtue in Herbs, little in men."
- Benjamin Franklin -

"I Give Thanks"

For this Day, this Time, this Place, this Journey,

For those who have journeyed to me, with me, from me,

For all of my Relations, For all of my Ancestors, For the Ancient ones,

For all that I have been given, and not given, For that I've been able to give

And most of all, For my Mother the Earth, without whom I would not EXIST